Results 141 to 150 of about 13,181 (300)

Comparison of real-time PCR, “in house” PCR, enzyme immunoassay and toxigenic culture in diagnosis of Clostridium difficile infection [PDF]

open access: gold, 2018
Natalia Azula   +9 more
openalex   +1 more source

Tumor Infiltrating Lymphocyte Therapy Combined With PD‐1/LAG‐3 Inhibition in Patients With Recurrent Platinum‐Resistant Ovarian Cancer

open access: yesInternational Journal of Cancer, EarlyView.
The detection of tumor‐infiltrating lymphocytes (TILs) is a positive prognostic factor in ovarian cancer. Moreover, TILs are significantly boosted by immunotherapy, though ovarian cancer patients have seen limited benefit from immune therapies. This study investigated the safety and feasibility of TIL therapy combined with PD‐1 and LAG‐3 inhibitors in ...
Tine J. Monberg   +9 more
wiley   +1 more source

Probiotics‐derived postbiotics improve host metabolic syndrome by activating the adipocyte thermogenic signaling pathway in high‐fat diet‐fed mice

open access: yesiMetaOmics, EarlyView.
This schematic illustrates how probiotics‐derived postbiotics (PLBK®1–5) combat high‐fat diet‐induced obesity. Postbiotics remodel gut microbiota, boosting beneficial metabolites. These metabolites activate adipocyte thermogenesis (Ucp1/AMPK pathway), resulting in reduced body weight, improved insulin sensitivity, and alleviated hepatic steatosis in ...
Ye Tian   +7 more
wiley   +1 more source

Impact of sink location on hand hygiene compliance after care of patients with Clostridium difficile infection: a cross-sectional study [PDF]

open access: gold, 2016
Alexander Deyneko   +5 more
openalex   +1 more source

Engineered Bacillus subtilis regulates intestinal barrier in ETEC K88‐infected piglets and modulates miR‐1250‐5p/NFκB pathway in IPEC‐J2

open access: yesiMetaOmics, EarlyView.
Upon enterotoxigenic Escherichia coli (ETEC) K88 infection, intestinal barrier function is disrupted with compromised tight junctions, accompanied by an exacerbated inflammatory response, proliferation of pathogenic Escherichia, and depletion of beneficial Lactobacillus paralimentarius.
Chaoyue Wen   +11 more
wiley   +1 more source

Investigating Clostridium difficile Infections across the U.S. : Emerging Infections Program \u2010 healthcare\u2010associated infections community interface activity

open access: yes
Clostridium difficile is a bacterium that causes diarrhea and more serious intestinal conditions. The organism is responsible for 337,000 infections and 14,000 deaths every year. C.

core  

Stopping C. difficile infections [PDF]

open access: yes
People getting medical care can catch serious infections called health care-associated infections (HAIs). While most types of HAIs are declining, one -- caused by the germ C. difficile -- remains at historically high levels. C.

core  

Clostridium difficile as a cause of hospital-related infections [PDF]

open access: yes, 2017
CILJ RADA: 1) Prikazati skup mjera i postupaka vezanih za proljev uzrokovan Clostridium difficile koji su od značenja za zdravstvenu njegu pacijenta; 2) prikazati smjernice za sprječavanje širenja Clostridium difficile na bolničkim odjelima; 3) prikazati
Knežević, Gabrijela
core  

Beyond “you are what you eat”: Unlocking gut microbiota‐mediated biotransformation of dietary phytochemicals

open access: yesiMetaOmics, EarlyView.
The “efficacy paradox” of phytochemicals, low bioavailability yet significant health benefits, is associated with gut microbiota, which biotransforms dietary precursors into bioactive metabolites, enabling systemic effects. Thus, health outcomes of diet depend not just on intake “the rainbow”, but on gut microbial metabolism, redefining “you are what ...
Peng Yang, Ren‐You Gan
wiley   +1 more source

Antimicrobials for treating Clostridium difficile infections

open access: yesJournal of Infection and Public Health, 2020
K. Sridharan
doaj   +1 more source

Home - About - Disclaimer - Privacy